Alcresta's Series B Round

Alcresta raised a round of funding on July 22, 2013.

Alcresta Therapeutics is dedicated to developing and commercializing novel enzyme-based products designed to treat gastrointestinal disorders and rare diseases. The company uses its technology platfor…

Articles about Alcresta's Series B Round: